AA
SGYP

Apriem Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Apriem Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,150
Closed -$19K – 751
2016
Q4 		$19K Hold
3,150
– – 0.01% 363
2016
Q3 		$17K Hold
3,150
– – 0.01% 350
2016
Q2 		$12K Sell
3,150
-1,000
-24% -$3.39K ﹤0.01% 396
2016
Q1 		$11K Buy
+4,150
New +$15K ﹤0.01% 374
2013
Q4 		– Sell
-301
Closed -$1K – 539
2013
Q3 		$1K Buy
+301
New +$1.35K ﹤0.01% 489

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return